SOMATIC MUTATIONS AT THE GLYCOPHORIN A LOCUS IN RADIATION EXPOSED INDIVIDUALS

受辐射个体中血型糖蛋白 A 基因座的体细胞突变

基本信息

项目摘要

There are two primary objectives for the glycophorin A-based somatic mutation analysis project. The first objective is to determine the magnitude and types of somatic mutational damage in liquidators exposed to radiation from the Chernobyl nuclear power accident as measured by the glycophorin A (GPA) assay. Analysis will be performed on blood samples from Russian liquidators with low-dose exposures and Russian controls, and will include measurements of the frequency of both hemizygous NO and homozygous NN variant erythrocytes. Measurements of the frequencies of somatic cell mutations at the GPA locus will be correlated with different indicators of genetic damage from other projects in the program project to provide a comprehensive analysis of genetic damage and potential health consequences in the liquidator population. The second objective is to utilize GPA data from the Chernobyl liquidator population to determine optimal strategies for detecting low-dose radiation exposures that may be applicable for future studies in other populations. Personal history data from questionnaires will be utilized to identify factors that contribute to inter-individual variability. Statistical procedures will be identified to adjust for confounding factors and facilitate differentiation between exposed and control populations. Results from the GPA assay will be compared with the results from other biodosimeters in the program project to determine the relative sensitivity and reliability of the different methods, and the power of the combined data for detecting low-dose radiation exposure in humans.
糖蛋白为基础的体细胞有两个主要目的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD G LANGLOIS其他文献

RICHARD G LANGLOIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD G LANGLOIS', 18)}}的其他基金

SOMATIC MUTATIONS AT THE GLYCOPHORIN A LOCUS IN RADIATION EXPOSED INDIVIDUALS
受辐射个体中血型糖蛋白 A 基因座的体细胞突变
  • 批准号:
    6203275
  • 财政年份:
    1999
  • 资助金额:
    $ 32.14万
  • 项目类别:
SOMATIC MUTATIONS AT THE GLYCOPHORIN A LOCUS IN RADIATION EXPOSED INDIVIDUALS
受辐射个体中血型糖蛋白 A 基因座的体细胞突变
  • 批准号:
    6216521
  • 财政年份:
    1999
  • 资助金额:
    $ 32.14万
  • 项目类别:
CORE--SAMPLE ACQUISITION FACILITY
核心——样品采集设施
  • 批准号:
    6216524
  • 财政年份:
    1999
  • 资助金额:
    $ 32.14万
  • 项目类别:
CORE--SAMPLE ACQUISITION FACILITY
核心——样品采集设施
  • 批准号:
    6203278
  • 财政年份:
    1999
  • 资助金额:
    $ 32.14万
  • 项目类别:
CORE--SAMPLE ACQUISITION FACILITY
核心——样品采集设施
  • 批准号:
    6102920
  • 财政年份:
    1998
  • 资助金额:
    $ 32.14万
  • 项目类别:
CORE--SAMPLE ACQUISITION FACILITY
核心——样品采集设施
  • 批准号:
    6237421
  • 财政年份:
    1997
  • 资助金额:
    $ 32.14万
  • 项目类别:
SOMATIC MUTATIONS AT THE GLYCOPHORIN A LOCUS IN RADIATION EXPOSED INDIVIDUALS
受辐射个体中血型糖蛋白 A 基因座的体细胞突变
  • 批准号:
    6237418
  • 财政年份:
    1997
  • 资助金额:
    $ 32.14万
  • 项目类别:
CORE--SAMPLE ACQUISITION FACILITY
核心——样品采集设施
  • 批准号:
    5209294
  • 财政年份:
  • 资助金额:
    $ 32.14万
  • 项目类别:
SOMATIC MUTATIONS AT THE GLYCOPHORIN A LOCUS IN RADIATION EXPOSED INDIVIDUALS
受辐射个体中血型糖蛋白 A 基因座的体细胞突变
  • 批准号:
    3731573
  • 财政年份:
  • 资助金额:
    $ 32.14万
  • 项目类别:
SOMATIC MUTATIONS AT THE GLYCOPHORIN A LOCUS IN RADIATION EXPOSED INDIVIDUALS
受辐射个体中血型糖蛋白 A 基因座的体细胞突变
  • 批准号:
    5209291
  • 财政年份:
  • 资助金额:
    $ 32.14万
  • 项目类别:

相似海外基金

Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
  • 批准号:
    10991546
  • 财政年份:
    2024
  • 资助金额:
    $ 32.14万
  • 项目类别:
The shielding role of the nuclear periphery against the genetic and non-genetic consequences of DNA damage (ChromoSENSOR)
核外围对 DNA 损伤的遗传和非遗传后果的屏蔽作用 (ChromoSENSOR)
  • 批准号:
    EP/Y027124/1
  • 财政年份:
    2023
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Research Grant
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
  • 批准号:
    10667881
  • 财政年份:
    2023
  • 资助金额:
    $ 32.14万
  • 项目类别:
Role of DNA damage and cellular senescence in osteoarthritis pathophysiology
DNA 损伤和细胞衰老在骨关节炎病理生理学中的作用
  • 批准号:
    10801026
  • 财政年份:
    2023
  • 资助金额:
    $ 32.14万
  • 项目类别:
Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability
ATR 在跨损伤合成中的作用对预防 DNA 损伤诱导的突变和染色体不稳定性的影响
  • 批准号:
    10634852
  • 财政年份:
    2023
  • 资助金额:
    $ 32.14万
  • 项目类别:
The interface of transcription, DNA damage and epigenetics: A therapeutic vulnerability of the EWS-FLI1 transcription factor
转录、DNA 损伤和表观遗传学的界面:EWS-FLI1 转录因子的治疗脆弱性
  • 批准号:
    10718793
  • 财政年份:
    2023
  • 资助金额:
    $ 32.14万
  • 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
  • 批准号:
    10747651
  • 财政年份:
    2023
  • 资助金额:
    $ 32.14万
  • 项目类别:
Targeting the function of BRCA1 in the DNA damage response network.
靶向 DNA 损伤反应网络中 BRCA1 的功能。
  • 批准号:
    2879783
  • 财政年份:
    2023
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Studentship
Elucidation of the mechanism underlying cellular senescence and aging induced by the continuous DNA damage
阐明持续DNA损伤引起的细胞衰老和老化的机制
  • 批准号:
    22KJ0646
  • 财政年份:
    2023
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma
TAZ 和 YAP 在 3D 基因组组织 DNA 损伤修复中的新作用以及胶质母细胞瘤的治疗耐药性
  • 批准号:
    10649830
  • 财政年份:
    2023
  • 资助金额:
    $ 32.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了